日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Collagen type IV alpha 6 promotes tumor progression and chemoresistance in ovarian cancer by activating the discoidin domain receptor 1 pathway

IV型胶原α6链通过激活盘状结构域受体1通路促进卵巢癌的肿瘤进展和化疗耐药性。

期刊:Oncogenesis
影响因子:6.4
doi:10.1038/s41389-025-00565-2
Wu, Yi-Hui; Wu, Pei-Ying; Huang, Yu-Fang; Chen, Chien-Chin; Huang, Soon-Cen; Cheng-Yang, Chou
信号转导
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Maternal Aspartame Exposure Induces Neonatal Pulmonary Metabolic Dysregulation and Redox Imbalance: A Multiomics Investigation of Gut Microbiota-Host Interactions

母体暴露于阿斯巴甜可诱发新生儿肺部代谢紊乱和氧化还原失衡：肠道菌群-宿主相互作用的多组学研究

期刊:Journal of Agricultural and Food Chemistry
影响因子:6.2
doi:10.1021/acs.jafc.5c08819
Ho, Sheng-Yuan; Lee, Cheng-Yang; Chou, Hsiu-Chu; Huang, Liang-Ti; Chen, Chung-Ming
微生物学
肠道菌群
代谢
发表日期：2025
文献求助 收藏

The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells

XI 型胶原蛋白 alpha 1 调节的高甲基化导致 miR-509-3p 表达下调，从而通过卵巢癌细胞中的 DNA 甲基转移酶 1/小泛素样修饰因子-3 轴促进癌症进展和化学耐药性

期刊:Journal of Ovarian Research
影响因子:3.8
doi:10.1186/s13048-023-01191-5
Yi-Hui Wu, Yu-Fang Huang, Pei-Ying Wu, Tzu-Hao Chang, Soon-Cen Huang #, Cheng-Yang Chou #
肿瘤
卵巢癌
肿瘤细胞
WB
发表日期：2023
文献求助 收藏

The Downregulation of miR-509-3p Expression by Collagen Type XI Alpha 1-Regulated Hypermethylation Facilitates Cancer Progression and Chemoresistance via the DNA Methyltransferase 1/Small Ubiquitin-like Modifier-3 Axis in Ovarian Cancer Cells

XI 型胶原 Alpha 1 调节的高甲基化导致 miR-509-3p 表达下调，从而通过 DNA 甲基转移酶 1/小泛素样修饰物-3 轴促进卵巢癌细胞中的癌症进展和化学耐药性

期刊:
影响因子:
doi:10.21203/rs.3.rs-2592453/v1
Yi-Hui Wu, Yu-Fang Huang, Pei-Ying Wu, Tzu-Hao Chang, Soon-Cen Huang, Cheng-Yang Chou
肿瘤
卵巢癌
肿瘤细胞
发表日期：2023
文献求助 收藏

COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells

COL11A1 通过调节卵巢癌细胞中的 NF-κB/IGFBP2 轴来激活癌症相关成纤维细胞

期刊:Oncogene
影响因子:6.9
doi:10.1038/s41388-021-01865-8
Yi-Hui Wu, Yu-Fang Huang, Tzu-Hao Chang, Chien-Chin Chen, Pei-Ying Wu, Soon-Cen Huang, Cheng-Yang Chou
信号转导
肿瘤
卵巢癌
肿瘤细胞
NF-κB
发表日期：2021
文献求助 收藏

miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1

miR-335 通过抑制 COL11A1 抑制卵巢癌细胞的侵袭性表型

期刊:Cancers
影响因子:
doi:10.3390/cancers13246257
Yi-Hui Wu, Yu-Fang Huang, Tzu-Hao Chang, Pei-Ying Wu, Tsung-Ying Hsieh, Sheng-Yen Hsiao, Soon-Cen Huang, Cheng-Yang Chou
肿瘤
卵巢癌
肿瘤细胞
WB
发表日期：2021
文献求助 收藏

Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca2+ entry-mediated turnover of focal adhesions

化疗耐药性卵巢癌通过增加池操纵的 Ca2+ 进入介导的粘着斑周转来增强其迁移能力

期刊:Journal of Biomedical Science
影响因子:9
doi:10.1186/s12929-020-00630-5
Ho-Kai Huang, Yi-Hsin Lin, Heng-Ai Chang, Yi-Shyun Lai, Ying-Chi Chen, Soon-Cen Huang, Cheng-Yang Chou, Wen-Tai Chiu
信号转导
肿瘤
卵巢癌
Adhesion/ECM
发表日期：2020
文献求助 收藏

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment

比较卵巢癌治疗中使用的 PI3K/Akt 抑制剂

期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2020.00206
Yi-Hui Wu, Yu-Fang Huang, Chien-Chin Chen, Chia-Yen Huang, Cheng-Yang Chou
信号转导
肿瘤
卵巢癌
IHC
PI3K/Akt
发表日期：2020
文献求助 收藏

Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression

Akt 抑制剂 SC66 通过抑制 COL11A1 表达增强化疗耐药卵巢癌细胞对顺铂的细胞敏感性

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-019-1555-8
Yi-Hui Wu, Yu-Fang Huang, Chien-Chin Chen, Cheng-Yang Chou
信号转导
肿瘤
卵巢癌
肿瘤细胞
IHC
PI3K/Akt
Human
发表日期：2019
文献求助 收藏

A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy

铂类化疗后 12 个月内首次复发的卵巢上皮癌、输卵管癌和腹膜癌女性患者接受曲恩汀联合卡铂和聚乙二醇化脂质体阿霉素的剂量递增研究

期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2019.00437
Yu-Fang Huang, Macus Tien Kuo, Yi-Sheng Liu, Ya-Min Cheng, Pei-Ying Wu, Cheng-Yang Chou
肿瘤
卵巢癌
发表日期：2019
文献求助 收藏